Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06665594 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Effect of TXA on Reducing Bruising After Filler Injection

StatusRecruiting
PhasePhase 2
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Site contact updatedv17
  2. Re-verified, no change to tracked fieldsv16
  3. Eligibility criteria shortened, about 4 wordsv15
  4. Start date changed from estimate of Dec 2025 to Dec 5, 2025v14
  5. Start date: Nov 2025 to Dec 2025v13
Show 11 earlier versionsHide 11 earlier versions
  1. Primary and study completion dates: Sep 2026 to Nov 2026
    • Start date: Oct 2025 to Nov 2025
    v12
  2. Start date: Sep 2025 to Oct 2025v11
  3. Eligibility criteria revised
    • Secondary endpoints: details revised at 10 of 10 entries
    v10
  4. Trial status: Not Yet Recruiting to Recruiting
    • Site details revised
    v9
  5. Primary and study completion dates: Jun 2026 to Sep 2026
    • Start date: Aug 2025 to Sep 2025
    v8
  6. Primary and study completion dates: May 2026 to Jun 2026
    • Start date: Jul 2025 to Aug 2025
    v7
  7. Start date: Jun 2025 to Jul 2025v6
  8. Start date: May 2025 to Jun 2025v5
  9. Primary and study completion dates: Mar 2026 to May 2026
    • Start date: Apr 2025 to May 2025
    v4
  10. Start date: Mar 2025 to Apr 2025v3
  11. Start date: Dec 2024 to Mar 2025
    • Primary and study completion dates: Dec 2025 to Mar 2026
    • Site contact updated
    v2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The goal of this clinical trial is to look at the effect tranexamic acid (TXA) may have on reducing bruising, swelling, and pain after facial filler injection. The main question it aims to answer is: * Does the addition of TXA to hyaluronic acid (HA) reduce bruising, swelling, and tenderness after HA injection? Participants will receive the study medication along with the standard facial filler injection and complete surveys.
Trial Details
NCT Number NCT06665594
Lead Sponsor University of Wisconsin, Madison
Conditions
(from sponsor)		 Facial Filler Injections, Hyaluronic Acid, Tranexamic Acid
Enrollment 40 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov